These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6181328

  • 1. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375).
    Schrör K, Darius H, Ohlendorf R, Matzky R, Klaus W.
    J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion.
    Johnson G, Tsao PS, Mulloy D, Lefer AM.
    J Pharmacol Exp Ther; 1990 Jan; 252(1):35-41. PubMed ID: 2153807
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist.
    Darius H, Thomsen T, Schrör K.
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):144-52. PubMed ID: 2441164
    [Abstract] [Full Text] [Related]

  • 11. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P, Colli S, Sirtori C, Tremoli E, Paoletti R.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Aug; 13():363-9. PubMed ID: 2408447
    [Abstract] [Full Text] [Related]

  • 12. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue.
    Huddleston CB, Hammon JW, Wareing TH, Lupinetti FM, Clanton JA, Collins JC, Bender HW.
    J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591
    [Abstract] [Full Text] [Related]

  • 13. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A, Oliva D, Folco GC, Giovanazzi S, Noe' MA, Fumagalli R, Nicosia S.
    Biomed Biochim Acta; 1988 Feb; 47(10-11):S104-7. PubMed ID: 3073757
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Studies on the protective effect of prostacyclin in acute myocardial ischemia.
    Ogletree ML, Lefer AM, Smith JB, Nicolaou KC.
    Eur J Pharmacol; 1979 Jun; 56(1-2):95-103. PubMed ID: 467518
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
    Yamamoto T, Satoh K, Nishimura T, Horikawa N, Mine T, Hirohashi T, Hara Y.
    Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of oxygen-centered free radical formation by the stable prostacyclin-mimetic iloprost (ZK 36 374) in acute myocardial ischemia.
    Thiemermann C, Steinhagen-Thiessen E, Schrör K.
    J Cardiovasc Pharmacol; 1984 Apr; 6(2):365-6. PubMed ID: 6200730
    [No Abstract] [Full Text] [Related]

  • 20. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
    Szekeres L, Krassói I, Pataricza J, Udvary E.
    Adv Myocardiol; 1985 Apr; 6():607-18. PubMed ID: 3887531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.